Showing 2 posts of 2 posts found.
Sanofi has been hit by generic erosion for key drugs in the second quarter, but the firm is confident it …
European regulators have begun an investigation into a possible risk of cancer in patients taking angiotensin II receptor inhibitors for …
Survey highlights mental health burden among rare disease patients and families
Addressing the rheumatic disease diagnostic gap in primary care
How chronic disease creates opportunity on diagnostic and therapeutic pipelines
EnteroBiotix appoints former GSK Chief Medical Officer to board
Stryker invests US$400m in CMR Surgical and secures option to acquire business